VolitionRx Limited (VNRX) Q2 FY26 Earnings Call

First-half revenue rose 112% year over year, while Q2 revenue stayed approximately $0.4 million.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-13
Length50 minutes
EPS$-0.78
EPS consensus$-0.68
Revenue$398657.00

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25 · Q2 FY25 · Q1 FY25

All VNRX earnings · Back to VNRX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.